Found: 74
Select item for more details and to access through your institution.
BOOK REVIEWS.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1991, v. 83, n. 17, p. 1254, doi. 10.1093/jnci/83.17.1254
- By:
- Publication type:
- Article
Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation for metastatic breast cancer.
- Published in:
- 1999
- By:
- Publication type:
- journal article
Cerebral spinal fluid involvement by Hodgkin's disease diagnosed by CSF cytology and immunocytochemistry.
- Published in:
- Diagnostic Cytopathology, 1999, v. 20, n. 4, p. 219, doi. 10.1002/(SICI)1097-0339(199904)20:4<219::AID-DC7>3.0.CO;2-D
- By:
- Publication type:
- Article
Effect of malnutrition-driven nutritional support protocol on clinical outcomes in autologous stem cell transplantation patients.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Recommended Guidelines for the Management of Autologous and Alogeneic Bone Marrow Transplantation.
- Published in:
- Annals of Internal Medicine, 1994, v. 120, n. 2, p. 143, doi. 10.7326/0003-4819-120-2-199401150-00008
- By:
- Publication type:
- Article
NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma.
- Published in:
- Nature Medicine, 2015, v. 21, n. 8, p. 914, doi. 10.1038/nm.3910
- By:
- Publication type:
- Article
Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T-cell transfer.
- Published in:
- Nature Medicine, 2005, v. 11, n. 11, p. 1230, doi. 10.1038/nm1310
- By:
- Publication type:
- Article
Symptom clusters and their impact on quality of life in multiple myeloma survivors: Secondary analysis of BMT CTN 0702 trial.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 4, p. 1429, doi. 10.1111/bjh.19326
- By:
- Publication type:
- Article
Does recipient body mass index inform donor selection for allogeneic haematopoietic cell transplantation?
- Published in:
- British Journal of Haematology, 2022, v. 197, n. 3, p. 326, doi. 10.1111/bjh.18108
- By:
- Publication type:
- Article
B‐cell maturation antigen chimeric antigen receptor T‐cell re‐expansion in a patient with myeloma following salvage programmed cell death protein 1 inhibitor‐based combination therapy.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 4, p. 851, doi. 10.1111/bjh.17397
- By:
- Publication type:
- Article
Heavy/light chain ratio normalization prior to transplant is of independent prognostic significance in multiple myeloma: a BMT CTN 0102 correlative study.
- Published in:
- British Journal of Haematology, 2017, v. 178, n. 5, p. 816, doi. 10.1111/bjh.14170
- By:
- Publication type:
- Article
Phase I, multicentre, dose-escalation trial of monotherapy with milatuzumab (humanized anti-CD74 monoclonal antibody) in relapsed or refractory multiple myeloma.
- Published in:
- British Journal of Haematology, 2013, v. 163, n. 4, p. 478, doi. 10.1111/bjh.12565
- By:
- Publication type:
- Article
One versus two sets of busulfan therapeutic drug monitoring in myeloablative allogeneic hematopoietic cell transplant.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 5, p. 802, doi. 10.1177/10781552231189199
- By:
- Publication type:
- Article
Day 4 vs. day 12 G-CSF administration following reduced intensity peripheral blood allogeneic stem cell transplant.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 4, p. 892, doi. 10.1177/10781552221080710
- By:
- Publication type:
- Article
Plerixafor mobilization leads to a lower ratio of CD34+ cells to total nucleated cells which results in greater storage costs.
- Published in:
- Journal of Clinical Apheresis, 2010, v. 25, n. 4, p. 202, doi. 10.1002/jca.20239
- By:
- Publication type:
- Article
Real‐world effectiveness of intensive chemotherapy with 7&3 versus venetoclax and hypomethylating agent in acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 8, p. 1254, doi. 10.1002/ajh.26991
- By:
- Publication type:
- Article
Trajectories of quality of life recovery and symptom burden after autologous hematopoietic cell transplantation in multiple myeloma.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 1, p. 140, doi. 10.1002/ajh.26596
- By:
- Publication type:
- Article
Gemtuzumab ozogamicin in the treatment of acute myeloid leukemia.
- Published in:
- Current Oncology Reports, 2002, v. 4, n. 5, p. 375, doi. 10.1007/s11912-002-0030-2
- By:
- Publication type:
- Article
Tailoring Initial Treatment for Newly Diagnosed, Transplantation-Eligible Multiple Myeloma.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 3, p. 7
- By:
- Publication type:
- Article
Progressive multifocal leukoencephalopathy in multiple myeloma.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 3, p. 322, doi. 10.1111/ejh.13909
- By:
- Publication type:
- Article
Bortezomib in Relapsed or Refractory Waldenström's Macroglobulinemia.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, n. 1, p. 74
- By:
- Publication type:
- Article
Bortezomib-Induced Tumor Lysis Syndrome in Multiple Myeloma.
- Published in:
- Clinical Lymphoma & Myeloma, 2006, v. 7, n. 3, p. 233
- By:
- Publication type:
- Article
Plasmacytic post-transplant lymphoproliferative disorder: a case series of nine patients.
- Published in:
- Transplant International, 2013, v. 26, n. 6, p. 616, doi. 10.1111/tri.12091
- By:
- Publication type:
- Article
Melphalan/Total body irradiation-conditioned myeloablative allogeneic hematopoietic cell transplantation for patients with primary plasma cell leukemia.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Identifying professional education gaps and barriers in multiple myeloma patient care: findings of the Managing Myeloma Continuing Educational Initiative Advisory Committee.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Effects of lenalidomide and dexamethasone treatment duration on survival in patients with relapsed or refractory multiple myeloma treated with lenalidomide and dexamethasone.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Effects of Lenalidomide and Dexamethasone Treatment Duration on Survival in Patients With Relapsed or Refractory Multiple Myeloma Treated With Lenalidomide and Dexamethasone.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2011, v. 11, n. 1, p. 38, doi. 10.3816/CLML.2010.n.120
- By:
- Publication type:
- Article
Lenalidomide in combination with dexamethasone at first relapse in comparison with its use as later salvage therapy in relapsed or refractory multiple myeloma.
- Published in:
- European Journal of Haematology, 2009, v. 82, n. 6, p. 426, doi. 10.1111/j.1600-0609.2009.01257.x
- By:
- Publication type:
- Article
Chronic lymphocytic leukemia: new concepts and emerging therapies.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33-positive acute myeloid leukemia in first recurrence.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33‐positive acute myeloid leukemia in first recurrence.
- Published in:
- Cancer (0008543X), 2005, v. 104, n. 7, p. 1442, doi. 10.1002/cncr.21326
- By:
- Publication type:
- Article
B cell maturation antigen-specific CAR T cells are clinically active in multiple myeloma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
OAB-013: Iberdomide (IBER) in combination with dexamethasone (DEX) and daratumumab (DARA), bortezomib (BORT), or carfilzomib (CFZ) in patients (pts) with relapsed/refractory multiple myeloma (RRMM).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S9, doi. 10.1016/S2152-2650(21)02087-5
- By:
- Publication type:
- Article
Infectious complications following Venetoclax-Proteasome Inhibitor based regimens in relapsed myeloma: a single center retrospective analysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e124, doi. 10.1016/j.clml.2019.09.206
- By:
- Publication type:
- Article
Oprozomib, pomalidomide, and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Nutrition-Related Outcomes for Autologous Stem Cell Transplantation Patients.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Randomized Phase II Trial of Combination Idiotype Vaccine and Anti-CD3/Anti-CD28 Costimulated Autologous T Cells in Patients with Multiple Myeloma Post-Autotransplantation.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e138, doi. 10.1016/j.clml.2017.03.250
- By:
- Publication type:
- Article
Overall Survival (OS) and Progression-Free Survival (PFS) Adjusted for Treatment Crossover in the CALGB/ECOG 100104 (Alliance) Study of Lenalidomide (LEN) Versus Placebo (PBO) Maintenance After Stem Cell Transplant (SCT) for Patients With Newly Diagnosed Multiple Myeloma
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e135, doi. 10.1016/j.clml.2017.03.244
- By:
- Publication type:
- Article
Oral Vancomycin Prophylaxis Is Highly Effective in Preventing Clostridium difficile Infection in Allogeneic Hematopoietic Cell Transplant Recipients.
- Published in:
- Clinical Infectious Diseases, 2019, v. 68, n. 12, p. 2003, doi. 10.1093/cid/ciy822
- By:
- Publication type:
- Article
Incorporation of extracorporeal photopheresis into a reduced intensity conditioning regimen in myelodysplastic syndrome and aggressive lymphoma: results from ECOG 1402 and 1902.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The evolving role of plerixafor in hematopoietic progenitor cell mobilization.
- Published in:
- Transfusion, 2013, v. 53, n. 10, p. 2314, doi. 10.1111/trf.12102
- By:
- Publication type:
- Article
Leukemic gingival infiltrate as an indicator of chemotherapeutic failure following monoclonal antibody therapy: a case report.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Risk of invasive fungal infections in patients with high‐risk MDS and AML receiving hypomethylating agents.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 7, p. 792, doi. 10.1002/ajh.25808
- By:
- Publication type:
- Article
Outcomes of patients with relapsed/refractory Hodgkin lymphoma progressing after autologous stem cell transplant in the current era of novel therapeutics: A retrospective analysis.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 9, p. 879, doi. 10.1002/ajh.24792
- By:
- Publication type:
- Article
Unrelated donors are associated with improved relapse-free survival compared to related donors in patients with myelodysplastic syndrome undergoing reduced intensity allogeneic stem cell transplantation.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 9, p. 883, doi. 10.1002/ajh.24424
- By:
- Publication type:
- Article
Autologous stem cell transplantation in first complete remission may not extend progression-free survival in patients with peripheral T cell lymphomas.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 7, p. 672, doi. 10.1002/ajh.24372
- By:
- Publication type:
- Article
Time to unrelated donor leukocyte infusion is longer, but incidence of GVHD and overall survival are similar for recipients of unrelated DLI compared to matched sibling DLI.
- Published in:
- American Journal of Hematology, 2016, v. 91, p. 426, doi. 10.1002/ajh.24308
- By:
- Publication type:
- Article
Infusion of CD3/CD28 costimulated umbilical cord blood T cells at the time of single umbilical cord blood transplantation may enhance engraftment.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 5, p. 453, doi. 10.1002/ajh.24303
- By:
- Publication type:
- Article
Time to unrelated donor leukocyte infusion is longer, but incidence of GVHD and overall survival are similar for recipients of unrelated DLI compared to matched sibling DLI.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 4, p. 426, doi. 10.1002/ajh.24308
- By:
- Publication type:
- Article
Safety and efficacy of upfront plerixafor + G-CSF versus placebo + G-CSF for mobilization of CD34<sup>+</sup> hematopoietic progenitor cells in patients ≥60 and <60 years of age with non-Hodgkin's lymphoma or multiple myeloma.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 12, p. 1017, doi. 10.1002/ajh.23561
- By:
- Publication type:
- Article